Tenderwize
Back to tender search

Spain – Pharmaceutical products – Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.

Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión SanitariaMelilla, SpainEUR 690,935 / ~EUR 690,93516 days leftopen
60

Opportunity Score

Confidence: 50%

Complexity: medium

16 days

Deadline

supplies

Contract

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Open procedure for the supply of three pharmaceutical active ingredients (Interferon Beta 1-A, Cannabino-Dronabinol, and Avelumab) to the University Hospital of Melilla, Spain. The contract is divided into three lots with a total estimated value of €690,934.65. Submission deadline is July 1, 2026. Only Spanish language submissions accepted. Documentation beyond the notice was not analyzed.

Strengths

Documents available

Open procedure

Medium complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Electronic submission via the provided platform
  • Submissions in Spanish only
  • Tenderers must submit documentation for price and quality criteria

Buyer

Name

Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria

Location

Melilla, ESP

Buyer profile

Open profile

Identifier

10000440056201

Lots (3)

#LOT-0001Medicamento Interferon BETA 1-A

Supply of Interferon Beta 1-A medicinal product.

EUR 532,917.4833600000ESP
#LOT-0002Medicamento Cannabino-Dronabinol

Supply of Cannabino-Dronabinol medicinal product.

8,925.8833600000ESP
#LOT-0003Medicamento Avelumab

Supply of Avelumab medicinal product.

149,091.2933600000ESP

Procurement Details

Publication

01 Jun 2026

Deadline

01 Jul 2026, 21:59

Procedure

open

Contract

supplies

Duration

1 YEAR

Language

SPA

Publication #

378009-2026

Classification

Performance: Spain

Documents (2)

Supply of interferon beta 1-A and ot Tender in Spain | TED 378009-2026